New diabetes combo drug put to the test in healthy volunteers
NCT ID NCT07538466
First seen Apr 21, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-stage study tests a new diabetes medicine called AD-123 in 50 healthy adults. Researchers want to see how safe it is and how the body processes it compared to taking its two components separately. The study does not involve treating diabetes directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus Yangji Hospita
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.